iproniazid has been researched along with Idiopathic Parkinson Disease in 9 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 5 (55.56) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (11.11) | 29.6817 |
2010's | 2 (22.22) | 24.3611 |
2020's | 1 (11.11) | 2.80 |
Authors | Studies |
---|---|
Matos, MJ | 1 |
Viña, D | 1 |
Picciau, C | 1 |
Orallo, F | 1 |
Santana, L | 1 |
Uriarte, E | 1 |
Distinto, S | 1 |
Yáñez, M | 1 |
Alcaro, S | 1 |
Cardia, MC | 1 |
Gaspari, M | 1 |
Sanna, ML | 1 |
Meleddu, R | 1 |
Ortuso, F | 1 |
Kirchmair, J | 1 |
Markt, P | 1 |
Bolasco, A | 1 |
Wolber, G | 1 |
Secci, D | 1 |
Maccioni, E | 1 |
Wang, Z | 1 |
Wu, J | 1 |
Yang, X | 1 |
Cai, P | 1 |
Liu, Q | 1 |
Wang, KDG | 1 |
Kong, L | 1 |
Wang, X | 1 |
Elzien Alamin Ali, H | 1 |
Ozalp, L | 1 |
Danış, Ö | 1 |
Odabaş, Z | 1 |
SIGWALD, J | 1 |
Hassler, R | 1 |
Gorkin, VZ | 1 |
Ernst, AM | 1 |
Dandiya, PC | 1 |
Bhargava, LP | 1 |
1 review available for iproniazid and Idiopathic Parkinson Disease
Article | Year |
---|---|
[New data on monoamine oxidase inhibitors].
Topics: Acridines; Animals; Brain; Cytoplasm; Hydrazines; Iproniazid; Isoquinolines; Liver; Membranes; Mitoc | 1971 |
8 other studies available for iproniazid and Idiopathic Parkinson Disease
Article | Year |
---|---|
Synthesis and evaluation of 6-methyl-3-phenylcoumarins as potent and selective MAO-B inhibitors.
Topics: Coumarins; Humans; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Parkinson Disease; Protein Isofo | 2009 |
Synthesis and biological assessment of novel 2-thiazolylhydrazones and computational analysis of their recognition by monoamine oxidase B.
Topics: Binding Sites; Humans; Hydrazones; Magnetic Resonance Spectroscopy; Models, Molecular; Molecular Dyn | 2012 |
Neuroprotective effects of benzyloxy substituted small molecule monoamine oxidase B inhibitors in Parkinson's disease.
Topics: Animals; Apoptosis; Cell Line; Cell Survival; Dose-Response Relationship, Drug; Mice; Mice, Inbred S | 2016 |
Synthesis and human monoamine oxidase inhibitory activity of novel C2-, C3- and C4-substituted phthalonitriles.
Topics: Humans; Molecular Docking Simulation; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Parkinson Dis | 2022 |
[Treatment of parkinsonian akinesia].
Topics: Apraxias; Humans; Imipramine; Iproniazid; Monoamine Oxidase Inhibitors; Parkinson Disease | 1961 |
[Correlations between chemical mediators (dopamine, serotonin, acetylcholine and gaba), muscular tone and rapidity of movement].
Topics: 5-Hydroxytryptophan; Acetylcholine; Alkaloids; Aminobutyrates; Animals; Dihydroxyphenylalanine; Dopa | 1972 |
Mode of action of apomorphine and dexamphetamine on gnawing compulsion in rats.
Topics: Animals; Apomorphine; Chemistry, Pharmaceutical; Compulsive Behavior; Dextroamphetamine; Dihydroxyph | 1967 |
The antiparkinsonian activity of monoamine oxidase inhibitors and other agents in rats and mice.
Topics: Animals; Dextroamphetamine; Diphenhydramine; Imipramine; Iproniazid; Isocarboxazid; Mice; Monoamine | 1968 |